The abstract is read at the publisher; the summary is JClub's.
In patient-derived diffuse intrinsic pontine glioma models, 6-thio-2'-deoxyguanosine (6-thio-dG; THIO) induces telomere dysfunction and radiosensitizes tumors, with synergistic antitumor effects across three H3 mutation subtypes.
- Why it matters: Diffuse midline glioma has limited durable benefit from radiotherapy, partly because adaptive DNA damage response pathways help tumor cells survive telomere-associated damage.
- What they did: THIO selectively suppressed DIPG proliferation, increased telomere dysfunction-induced foci (TIFs), {gamma}H2AX, G2/M arrest, and apoptosis in vitro, then increased intratumoral TIFs and prolonged survival in orthotopic xenografts. Transcriptomics showed stress-response activation and downregulation of E2F, mitotic, and metabolism programs, while ATM/ATR signaling sequentially activated; THIO plus ionizing radiation produced synergistic effects.
- The result: In vivo, THIO combined with ionizing radiation significantly improved therapeutic efficacy and prolonged median survival versus monotherapy, including radiotherapy alone, and ATM or ATR inhibition attenuated THIO-driven checkpoint arrest while increasing apoptosis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.